Sonnet BioTherapeutics
SONN
SONN
23 hedge funds and large institutions have $2.11M invested in Sonnet BioTherapeutics in 2023 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 6 closing their positions.
Holders
23
Holders Change
+5
Holders Change %
+27.78%
% of All Funds
0.36%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
11
Increased
7
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–